These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19473102)

  • 1. In vivo comparison of hard tissue regeneration with human mesenchymal stem cells processed with either the FICOLL method or the BMAC method.
    Sauerbier S; Stricker A; Kuschnierz J; Bühler F; Oshima T; Xavier SP; Schmelzeisen R; Gutwald R
    Tissue Eng Part C Methods; 2010 Apr; 16(2):215-23. PubMed ID: 19473102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue.
    Hayashi O; Katsube Y; Hirose M; Ohgushi H; Ito H
    Calcif Tissue Int; 2008 Mar; 82(3):238-47. PubMed ID: 18305886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo comparison of hard tissue regeneration with ovine mesenchymal stem cells processed with either the FICOLL method or the BMAC method.
    Ardjomandi N; Duttenhoefer F; Xavier S; Oshima T; Kuenz A; Sauerbier S
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1177-83. PubMed ID: 26138380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering.
    Park KH; Kim H; Moon S; Na K
    J Biosci Bioeng; 2009 Dec; 108(6):530-7. PubMed ID: 19914589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tissue-like construct of human bone marrow MSCs composite scaffold support in vivo ectopic bone formation.
    Ben-David D; Kizhner T; Livne E; Srouji S
    J Tissue Eng Regen Med; 2010 Jan; 4(1):30-7. PubMed ID: 19842114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow concentrate and bovine bone mineral for sinus floor augmentation: a controlled, randomized, single-blinded clinical and histological trial--per-protocol analysis.
    Sauerbier S; Rickert D; Gutwald R; Nagursky H; Oshima T; Xavier SP; Christmann J; Kurz P; Menne D; Vissink A; Raghoebar G; Schmelzeisen R; Wagner W; Koch FP
    Tissue Eng Part A; 2011 Sep; 17(17-18):2187-97. PubMed ID: 21529247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture and differentiation of osteoblasts on coral scaffold from human bone marrow mesenchymal stem cells.
    Tran CT; Gargiulo C; Thao HD; Tuan HM; Filgueira L; Michael Strong D
    Cell Tissue Bank; 2011 Nov; 12(4):247-61. PubMed ID: 20703817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
    Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
    Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease.
    Salvadè A; Belotti D; Donzelli E; D'Amico G; Gaipa G; Renoldi G; Carini F; Baldoni M; Pogliani E; Tredici G; Biondi A; Biagi E
    Cytotherapy; 2007; 9(5):427-38. PubMed ID: 17786604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
    Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
    Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation: an in vitro study.
    Turhani D; Watzinger E; Weissenböck M; Yerit K; Cvikl B; Thurnher D; Ewers R
    Clin Oral Implants Res; 2005 Aug; 16(4):417-24. PubMed ID: 16117765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L; Li G; Chan KM; Wang Y; Tang PF
    Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells and inorganic bovine bone mineral in sinus augmentation: comparison with augmentation by autologous bone in adult sheep.
    Gutwald R; Haberstroh J; Kuschnierz J; Kister C; Lysek DA; Maglione M; Xavier SP; Oshima T; Schmelzeisen R; Sauerbier S
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):285-90. PubMed ID: 19665265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feasibility of useful cell-based therapy by bone regeneration with deciduous tooth stem cells, dental pulp stem cells, or bone-marrow-derived mesenchymal stem cells for clinical study using tissue engineering technology.
    Yamada Y; Nakamura S; Ito K; Sugito T; Yoshimi R; Nagasaka T; Ueda M
    Tissue Eng Part A; 2010 Jun; 16(6):1891-900. PubMed ID: 20067397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cell-based approaches in maxillary sinus augmentation procedures.
    Park JB
    J Craniofac Surg; 2010 Mar; 21(2):557-60. PubMed ID: 20216438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
    J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate.
    Matsushima A; Kotobuki N; Tadokoro M; Kawate K; Yajima H; Takakura Y; Ohgushi H
    Artif Organs; 2009 Jun; 33(6):474-81. PubMed ID: 19473144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.